References
- Greenwood M J, Seftel M D, Richardson C, Barbaric D, Barnett M J, Bruyer H, et al. Leukocyte count as a predictor of death during remission induction in acute myeloid leukemia. Leuk Lymphoma 2006; 47: 1245–1252
- Estey E, Smith T L, Keating M J, McCredie K B, Gehan E A, Freireich E J. Prediction of survival during induction therapy in patients with newly diagnosed acute myeloblastic leukemia. Leukemia 1989; 3: 257–263
- Estey E. Reducing mortality associated with immediate treatment complications of adult leukemias. Semin Hematol 2001; 38: 32–37
- Estey E H, Pierce S, Keating M J. Identification of a group of AML/MDS patients with a relatively favorable prognosis who have chromosome 5 and/or 7 abnormalities. Haematologica 2000; 85: 246–249
- Kottaridis P D, Gale R E, Frew M E, Harrison G, Langabeer S E, Belton A A, et al. The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials. Blood 2001; 98: 1752–1759